Case Report

A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions

Figure 1

Clinical course of the patient during induction therapy with azacitidine. ESA: erythropoiesis-stimulating agent; G-CSF: granulocyte colony-stimulating factor.